https://www.selleckchem.com/pr....oducts/filgotinib.ht
Melanoma ranks 19th among malignancies overall and second among cutaneous types. The incidence worldwide has been on the rise over the last seven decades. Various prognostic factors have been assessed and found to have a profound impact on patient outcome. However, no such studies have been attempted in our population. Our study aimed to have an insight into the behavior of malignant melanoma in our population. Cases of cutaneous malignant melanoma treated and followed up at our institute were included in this study. Cases of mucosal
Like
Comment
Share
